Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
AMI ORGANICS ADCOCK INGRAM |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
AMI ORGANICS Mar-23 |
ADCOCK INGRAM Jun-14 |
AMI ORGANICS/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,182 | 316 | - | |
Low | Rs | 826 | 228 | - | |
Sales per share (Unadj.) | Rs | 169.2 | 94.0 | - | |
Earnings per share (Unadj.) | Rs | 22.9 | -23.7 | - | |
Cash flow per share (Unadj.) | Rs | 26.2 | -19.6 | - | |
Dividends per share (Unadj.) | Rs | 3.00 | 0 | - | |
Avg Dividend yield | % | 0.3 | 0 | - | |
Book value per share (Unadj.) | Rs | 163.0 | 73.8 | - | |
Shares outstanding (eoy) | m | 36.44 | 168.78 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 5.9 | 2.9 | 205.1% | |
Avg P/E ratio | x | 43.9 | -11.5 | -382.6% | |
P/CF ratio (eoy) | x | 38.3 | -13.9 | -276.1% | |
Price / Book Value ratio | x | 6.2 | 3.7 | 167.1% | |
Dividend payout | % | 13.1 | 0 | - | |
Avg Mkt Cap | Rs m | 36,590 | 45,919 | 79.7% | |
No. of employees | `000 | NA | 4.3 | 0.0% | |
Total wages/salary | Rs m | 488 | 2,882 | 16.9% | |
Avg. sales/employee | Rs Th | 0 | 3,696.8 | - | |
Avg. wages/employee | Rs Th | 0 | 671.3 | - | |
Avg. net profit/employee | Rs Th | 0 | -931.5 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 6,167 | 15,870 | 38.9% | |
Other income | Rs m | 43 | 111 | 38.9% | |
Total revenues | Rs m | 6,211 | 15,982 | 38.9% | |
Gross profit | Rs m | 1,226 | -2,750 | -44.6% | |
Depreciation | Rs m | 123 | 685 | 18.0% | |
Interest | Rs m | 24 | 430 | 5.6% | |
Profit before tax | Rs m | 1,122 | -3,754 | -29.9% | |
Minority Interest | Rs m | 0 | -10 | -0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 289 | 235 | 123.1% | |
Profit after tax | Rs m | 833 | -3,999 | -20.8% | |
Gross profit margin | % | 19.9 | -17.3 | -114.7% | |
Effective tax rate | % | 25.7 | -6.2 | -412.1% | |
Net profit margin | % | 13.5 | -25.2 | -53.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 4,701 | 11,624 | 40.4% | |
Current liabilities | Rs m | 1,628 | 6,540 | 24.9% | |
Net working cap to sales | % | 49.8 | 32.0 | 155.5% | |
Current ratio | x | 2.9 | 1.8 | 162.4% | |
Inventory Days | Days | 5 | 111 | 4.3% | |
Debtors Days | Days | 1,363 | 124 | 1,099.5% | |
Net fixed assets | Rs m | 2,969 | 6,775 | 43.8% | |
Share capital | Rs m | 364 | 74 | 494.5% | |
Net worth | Rs m | 5,940 | 12,457 | 47.7% | |
Long term debt | Rs m | 6 | 4,377 | 0.1% | |
Total assets | Rs m | 7,669 | 23,531 | 32.6% | |
Interest coverage | x | 47.5 | -7.7 | -614.4% | |
Debt to equity ratio | x | 0 | 0.4 | 0.3% | |
Sales to assets ratio | x | 0.8 | 0.7 | 119.2% | |
Return on assets | % | 11.2 | -15.2 | -73.7% | |
Return on equity | % | 14.0 | -32.1 | -43.7% | |
Return on capital | % | 19.3 | -19.8 | -97.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 655 | 1,355 | 48.4% | |
From Investments | Rs m | -330 | -416 | 79.4% | |
From Financial Activity | Rs m | -123 | 3,973 | -3.1% | |
Net Cashflow | Rs m | 202 | 4,912 | 4.1% |
Compare AMI ORGANICS With: MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Compare AMI ORGANICS With: BERYL DRUGS ZENITH DRUGS LTD. ZENOTECH LABS ANG LIFESCIENCES INDIA HEMO ORGANIC
Asian markets traded higher on Tuesday following overnight gain on Wall Street.